Plus Therapeutics, Inc. Email Format
Pharmaceutical ManufacturingTexas, United States11-50 Employees
Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate REYOBIQ™ is being evaluated in the multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.